Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients

American Journal of Hypertension

Volumn 14, Issue 9 I, 2001, Pages 908-913

  Hirano, Tsutomu ^a,c   Yoshino, Gen ^b   Kashiwazaki, Koichi ^a   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Doxazosin; Hypertension; Remnant like particle cholesterol; Small dense low density lipoprotein; Triglyceride; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; C PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MALE; PARTICLE SIZE; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTIHYPERTENSIVE AGENTS; APOLIPOPROTEINS; BLOOD GLUCOSE; BLOOD PRESSURE; C-PEPTIDE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DOXAZOSIN; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PREVALENCE; TRIGLYCERIDES;

EID: 0034828280     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(01)02141-0     Document Type: Article

References (30)

1. An overview of the metaanalyses of the hypertension treatment trials
2. The coronary artery disease paradox: The role of hyperinsulinemia and insulin resistance and implications for therapy
3. Primary prevention of coronary heart disease: Guidance from Framingham: A statement for healthcare professionals from the AHA Task Force on Risk Reduction
4. Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men. Relationship to changes in skeletal muscle blood flow
5. Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men
6. Low-density lipoprotein subclass patterns and risk of myocardial infarction
7. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study
8. Small dense low-density lipoprotein in Japanese men with coronary artery disease
9. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease
10. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease
11. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study
12. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
13. Impact of diabetes on coronary artery disease in women and men: A meta-analysis of prospective studies
14. Dyslipidemia in diabetes mellitus
15. Nondenaturing polyacrylamide gradient gel electrophoresis
16. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels
17. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
18. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
19. Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria
20. Von Willebrand factor and endothelial damage in essential hypertension
21. Effects of doxazosin and atenolol on circulating endothelin-1 and von Willebrand factor in hypertensive middle-aged men
22. Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome
23. Doxazosin improves insulin sensitivity in hypertensive patients
24. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E
25. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles
26. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo
27. Troglitazone and small low-density lipoprotein in type 2 diabetes
28. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels
29. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries
30. Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers